Skip to content
DraconiticResearch
Search Sources API
203,952 studies31 sourcesUpdated 17 min ago
Peer-reviewedCC BY-NC-NDThe journal of liquid biopsy

Web-based application of integrated clinico-genomic prognostic nomograms in metastatic castration-resistant prostate cancer

  • Muhammad Zaki Fadlullah1
  • Benjamin Haaland2
  • Liang Wang3
  • Aik Choon Tan1
  • Manish Kohli4
4 affiliations
  1. 1Departments of Oncological Sciences and Biomedical Informatics, University of Utah-Huntsman Cancer Institute, Salt Lake City, UT, USA
  2. 2Pentara Corporation, Salt Lake City, UT, USA
  3. 3Department of Tumor Biology, H. Lee Moffitt Cancer Center, Tampa, FL, 33612, USA
  4. 4Division of Oncology, Department of Medicine, University of Utah-Huntsman Cancer Institute, Salt Lake City, UT, USA
Read full textPDFCite

Related

  1. Baseline serum carcinoembryonic antigen (CEA) is an independent prognostic biomarker for metastatic castration-resistant prostate cancer (mCRPC) patients receiving 177Lu-PSMA therapy
    Emilio Francesco Giunta, Irene Marini, Ilaria Grassi +11
    European Journal of Nuclear Medicine and Molecular ImagingPeer-reviewedCC BY-NC-ND 4.0Full textMedical imaging & radiologyPMC
  2. Serum [-2]proPSA as a Candidate Phenotypic Correlate of Molecular Alterations and Prognostic Marker in Metastatic Castration-Resistant Prostate Cancer.
    Vincenza Conteduca, Marianna Garofoli, Giuseppina Bruno +5
    Prostate cancerPeer-reviewedCC BYFull textGeneral medicineEurope PMCPMC
  3. Peripheral blood mRNA-based prognostic model for progression to metastatic castration-resistant prostate cancer and identification of SLC6A8 as a glycolysis-promoting biomarker
    Sicong Li, Heling Zhou, Yi Wu +7
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  4. Prognostic Value of Baseline High-Uptake PSMA Tumor Volume Fraction in Metastatic Castration-Resistant Prostate Cancer Patients Treated with [177Lu]Lu-PSMA Radioligand Therapy
    Marco Cuzzocrea, Giovanna Pecoraro, Cesare Michele Iacovitti +5
    CancersPeer-reviewedCC BY 4.0Full textMedical imaging & radiologyCrossrefEurope PMC
  5. A novel multiplex digital PCR assay for simultaneous quantification of androgen receptor amplification, mutations, and splice variants in cell-free nucleic acids from metastatic castration-resistant prostate cancer
    Yijun Tian, Jodie Wong, Filip Ionescu +4
    The journal of liquid biopsyPeer-reviewedCC BY-NC-NDFull textEurope PMC

Cite

BibTeXRIS
BibTeX
@article{fadlullah2026webbased,
  title = {{Web-based application of integrated clinico-genomic prognostic nomograms in metastatic castration-resistant prostate cancer}},
  author = {Muhammad Zaki Fadlullah and Benjamin Haaland and Liang Wang and Aik Choon Tan and Manish Kohli},
  journal = {The journal of liquid biopsy},
  year = {2026},
  month = sep,
  url = {https://europepmc.org/article/PMC/PMC13656970},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Web-based application of integrated clinico-genomic prognostic nomograms in metastatic castration-resistant prostate cancer
AU  - Muhammad Zaki Fadlullah
AU  - Benjamin Haaland
AU  - Liang Wang
AU  - Aik Choon Tan
AU  - Manish Kohli
PY  - 2026
DA  - 2026/09/28
JO  - The journal of liquid biopsy
UR  - https://europepmc.org/article/PMC/PMC13656970
SN  - 2950-1954
ER  -